Santen Pharmaceutical Co., Ltd.
4536
Rank in Stocks
#4330
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research,... Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.
Share Price
$11.35
Last synced: 2026-10-16
Market Cap
$3.65B
Change (1 day)
1.55%
Change (1 year)
-0.91%
Country
JP
Trade Santen Pharmaceutical Co., Ltd. (4536)
Category
Healthcare
Market Capitalization of Santen Pharmaceutical Co., Ltd.(4536)
Market Cap: $3.65B
As of October 2026 Santen Pharmaceutical Co., Ltd. has a market cap of $3.65B. This makes Santen Pharmaceutical Co., Ltd. the world's 4330th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Santen Pharmaceutical Co., Ltd. from 2010 to 2026
4536 compared with Top 5 Most Popular stocks
